[Federal Register Volume 64, Number 123 (Monday, June 28, 1999)]
[Notices]
[Page 34659]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-16314]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Arthritis Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Arthritis Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on July 21, 1999, 8 a.m. to
5 p.m.
Location: Holiday Inn, Walker/Whetstone Salons, Two Montgomery
Village Ave., Gaithersburg, MD.
Contact Person: Kathleen R. Reedy or LaNise S. Giles, Center for
Drug Evaluation and Research (HFD-21), Food and Drug Administration,
5600 Fishers Lane, (for express delivery, 5630 Fishers Lane, rm. 1093),
Rockville, MD 20857, 301-827-7001, or email reedyk@cder.fda.gov or FDA
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in
the Washington, DC area), code 12532. Please call the Information Line
for up-to-date information on this meeting.
Agenda: The committee will discuss the evidence needed to establish
that a drug product has a beneficial effect on joint structure in
patients with osteoarthritis.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by July 12, 1999.
Oral presentations from the public will be scheduled between
approximately 11 a.m. and 12 noon. Time allotted for each presentation
may be limited. Those desiring to make formal oral presentations should
notify the contact person before July 12, 1999, and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their
presentation.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: June 18, 1999.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 99-16314 Filed 6-25-99; 8:45 am]
BILLING CODE 4160-01-F
